Is Rocket Pharmaceuticals, Inc. overvalued?

Rocket Pharmaceuticals, Inc. (RCKT) — key valuation metrics and fundamentals.

No verdict

Price

$2.30

Fair value

—

Current P/E

—

Normal P/E

—

Market cap

$252.5M

Dividend yield

0.0%

Return on equity

-5.8%

Sector

Healthcare

Fair value compares RCKT's current P/E to its own historical "normal" P/E (FAST Graphs-style). Updated 12 Nov 2026.

Related stocks